Close Menu

NEW YORK (GenomeWeb) – Royal Philips announced last week that it and collaborators have been awarded a €6.3 million ($7.5 million) grant to develop an approach for personalized cancer treatment that combines liquid biopsy with magnetic resonance imaging (MRI).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.